3 result(s) displayed (1 - 3 of 3):

Medtronic earnings reflect strategic maneuvering (from Corporate Dealmaker)

Medtronic Inc.'s (NYSE:MDT) efforts to balance growth and downsizing in 2009 appear to be delivering results. The medical device maker reported a 59% increase in second-quarter profit on Tuesday, earning $868 million. Revenue was up 8% to $3.84 billion. Sales were up across Medtronic's product line with stent sales rising...

Posted on November 24, 2009 12:22 PM

Medtronic, Abbott settle IP dispute (from Corporate Dealmaker)

Medtronic Inc. (NYSE:MDT) and Abbott Laboratories (NYSE:ABT) have settled a long-running intellectual property dispute. Under terms of the deal, Medtronic will pay Abbott $400 million, and the companies have agreed not to sue one another over coronary stent systems or IP for at least 10 years. Medtronic also agreed to...

Posted on July 27, 2009 2:55 PM

Abbott's well-timed deal for Advanced Medical Optics (from Corporate Dealmaker)

Looking for examples of how the recession is creating opportunities for prepared, financially strong acquirers? Check out the deal Abbott Laboratories announced Monday morning to buy Advanced Medical Optics Inc. for nearly $2.8 billion including assumed debt. On one hand, the $22 per share price was a 149% premium to...

Posted on January 12, 2009 12:19 PM